Instituto de Diagnóstico S.A. Stock

Equities

INDISA

CL0000001587

Healthcare Facilities & Services

End-of-day quote Santiago S.E. 06:00:00 2024-05-05 pm EDT 5-day change 1st Jan Change
1,467 CLP 0.00% Intraday chart for Instituto de Diagnóstico S.A. -0.31% +16.17%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
Sales 2022 191B 204M Sales 2023 219B 234M Capitalization 178B 190M
Net income 2022 13.05B 13.92M Net income 2023 144M 154K EV / Sales 2022 1.7 x
Net Debt 2022 98.63B 105M Net Debt 2023 99.27B 106M EV / Sales 2023 1.27 x
P/E ratio 2022
17.4 x
P/E ratio 2023
1,234 x
Employees 3,080
Yield 2022
1.73%
Yield 2023
-
Free-Float 67.25%
More Fundamentals * Assessed data
Dynamic Chart
Instituto de Diagnóstico S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Full Year Ended December 31, 2022 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
Instituto de Diagn?stico S.A. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021 CI
Instituto de Diagnóstico S.A. Reports Earnings Results for the Second Quarter Ended June 30, 2021 CI
Instituto De Diagnóstico S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021 CI
Instituto De Diagn?Stico S.A. Reports Earnings Results for the Full Year Ended December 31, 2020 CI
More news
1 week-0.31%
Current month-0.31%
1 month-0.81%
3 months+8.54%
6 months+2.97%
Current year+16.17%
More quotes
1 week
1 457.90
Extreme 1457.9
1 472.00
1 month
1 448.00
Extreme 1448
1 500.00
Current year
1 199.20
Extreme 1199.2
1 530.00
1 year
1 170.00
Extreme 1170
1 530.00
3 years
1 170.00
Extreme 1170
1 800.10
5 years
1 170.00
Extreme 1170
2 195.00
10 years
1 170.00
Extreme 1170
2 679.48
More quotes
Managers TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - 06-02-19
Chief Tech/Sci/R&D Officer - 04-04-05
Members of the board TitleAgeSince
Director/Board Member - -
Chairman - -
Director/Board Member 72 -
More insiders
Date Price Change Volume
24-05-07 1,467 0.00% 928
24-05-06 1,467 0.00% 1,749
24-05-03 1,467 -0.31% 42,869
24-05-02 1,472 0.00% 0
24-04-30 1,472 0.00% 0

End-of-day quote Santiago S.E., May 05, 2024

More quotes
Instituto de Diagnostico SA is a Chile-based company engaged in the healthcare sector. The Company manages and operates Clinica Indisa, a private clinic located in the Santiago Metropolitan Region, which provides such hospital and outpatient services, as internal medicine admission and surgery, intensive and intermediate care units, pediatrics and neonatology, post-surgery recuperation, clinical laboratories, blood donation, radiology, endocrinology, computerized tomography, magnetic resonance imaging (MRI), nuclear medicine, hemodialysis and other outpatient procedures and services that cover all areas of medicine. As of December 31, 2011, the Company owned such subsidiaries as Servicios Integrados de Salud Ltda, Servicios Complementarios de Salud Ltda, Inmobiliaria San Cristobal SA and Indisa Laboratorio Ltda.
More about the company
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
1,467 CLP
Average target price
1,900 CLP
Spread / Average Target
+29.48%
Consensus
  1. Stock Market
  2. Equities
  3. INDISA Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW